Latest news

Medtronic Announces 9 Percent Increase In Cash Dividend
Schibsted ASA (SCHA/SCHB) - Mandatory notification of trade - Long Term Incentive Plan
VINCI : VINCI Energies wins an important smart lighting project in Australia
Dalradian files NI 43-101 technical report for the updated mineral resource statement for the Curraghinalt gold deposit
Shire plc: Large-Scale European Review Suggests Disparity in Symptom Recognition and Standardized Treatment for Metastatic Adenocarcinoma of the Pancreas
AJC Mourns Death of Charles Krauthammer
Tint World® Announces Growth Plans, Unveils Updated Franchise Opportunity Website
Changes to the Roche Enlarged Corporate Executive Committee
NN Group to sell Dutch residential real estate portfolio to Vesteda
UK's MHRA renews Early Access to Medicines Scheme Scientific Opinion for Santhera's Raxone® (idebenone) in Duchenne Muscular Dystrophy
Tidewater announces fifteen-year liquids agreement with investment grade counterparty, successful turnaround at BRC and second quarter 2018 dividend
Ellomay Capital Announces the Execution of a PPA in Connection With the Talasol Project
Global Functional Coil Coatings Market Expected to Reach $509 Million by 2024
Media Advisory - Royal Canadian Mint to unveil silver coin celebrating the 150th anniversary of the Royal Astronomical Society of Canada
Universal mCloud Announces Feature in BTV Broadcast
Prometic Presents New Data on NASH Drug Candidate PBI-4547
/R E P E A T -- REVISED Media Advisory: Infrastructure Announcement in Toronto/
TVI Announces the Results of its Annual Meeting of Shareholders
Media Advisory - Itinerary for Friday, June 22, 2018
Replimune Appoints Dieter K. Weinand to Board of Directors
Friday, 22 June 2018, 12:45

Medtronic Announces 9 Percent Increase In Cash Dividend

Medtronic plc

41st Consecutive Year of Dividend Increases

DUBLIN - June 22, 2018 - The board of directors of Medtronic plc (NYSE: MDT) today approved a 9 percent increase in its quarterly cash dividend, raising the quarterly amount to $0.50 per ordinary share. This would translate into an annual amount of $2.00 per ordinary share, or a dividend per share payout ratio of 42 percent of prior fiscal year non-GAAP diluted earnings per share (EPS). Today's announcement marks the 41st consecutive year of an increase in the dividend payment for Medtronic, a constituent of the S&P 500 Dividend Aristocrats index. Including today's increase, Medtronic's dividend per share has grown by 300 percent since fiscal year 2008 and has grown at a 17 percent compounded annual growth rate over the past 41 years.

"We are committed to creating shareholder value through efficient and disciplined capital allocation, and this starts with providing a strong and growing dividend to our shareholders. Today's dividend increase reflects the confidence of our board and management team in the strength of the company's cash flow generation," said Omar Ishrak, Medtronic chairman and chief executive officer. "We are focused on continuing to improve our cash flow conversion, creating additional capital that can be both reinvested to drive future growth and returned to our shareholders."

Medtronic has a strong track record of returning capital to its shareholders, including returning $4.3 billion in fiscal year 2018.  The company remains committed to returning a minimum of 50 percent of its free cash flow to shareholders through dividends and share repurchases. Medtronic continues to expect to grow its dividend in line with earnings, and it is focused on maintaining a payout ratio on prior fiscal year non-GAAP EPS around 40 percent. The dividend is payable on July 25, 2018, to shareholders of record at the close of business on July 6, 2018.

About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 86,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

-end-

Contacts:
Fernando Vivanco
Public Relations
+1-763-505-3780

Ryan Weispfenning
Investor Relations
+1-763-505-4626





This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Medtronic plc via Globenewswire

Test our partner's services and trading platform with a free demo account during 30 days

Trade with confidence
Get up to 100% bonus on your First deposit!